Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Bedrock Bedrock +19.53%
#4 Cysic Cysic +19.17%
#5 Fabric Protocol Fabric Protocol +15.42%
#6 Perle Perle +8.92%
#7 Nockchain Nockchain +8.81%
#8 Arowana Arowana +8.41%
#9 Velvet Velvet +6.80%
#10 stake.link stake.link +6.79%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
NewcelX Ltd. NewcelX Ltd.

NewcelX Ltd.

NCEL
Rank in Stocks #37735
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich,... NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Share Price
$3.29
Last synced: 2026-08-14
Market Cap
$1.48M
Change (1 day)
-8.63%
Change (1 year)
-86.89%
Country
CH
Trade NewcelX Ltd. (NCEL)

Category

Healthcare
Revenue for NewcelX Ltd. (NCEL)
Revenue in Aug 2026 TTM: 0
According to NewcelX Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NewcelX Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE